<p>(A) In the presence of Sbi and Efb (lane 1 and 2) the C3 α-chain decreased and C3 cleavage products (indicated by arrows) appeared. CRASP-5 did not show this effect. C3 was incubated with SAK-activated plasmin (PL<sub>SAK</sub>) in the presence of Sbi, Efb, CRASP-5, or HSA. Samples were separated by SDS-PAGE and C3 cleavage products were visualized using Western blot analysis. (B) A similar assay was performed with uPa as activator and this time the fragments Sbi 1–2, Sbi 3–4, and Efb-C were assayed. Sbi 3–4 (lane 5 and 6) and Efb-C (lane 8 and 9) enhanced the plasmin mediated C3 cleavage as seen by the appearance of small cleavage products. The IgG-binding Sbi 1–2 (mobility of 17 kDa) did not affect the C3 cleavage pattern (lane 2 and 3...
<p><b>A</b>: Formation of C3a in 2.5% serum incubated in wells coated with fibrin, the known complem...
<p>Proteolysis of <sup>125</sup>I-C3b was analyzed by the intensity of the α’-chain in autoradiograp...
<p>A-C) Cleavage of human complement factors A) C3, B) C3a and C) C5a by whole cell pellets (4x10<su...
<p>(A) Sbi 3–4 (lane 5–6) and Efb-C (lane 8–9) enhanced cleavage of C3b by plasmin, as seen by the a...
<p>(A+B) Plasminogen (PLG) bound to the fragments 3–4 of Sbi (A) and the C-terminus of Efb (B). Sbi ...
<p>Microtiter plates were coated with recombinant Tuf proteins (10 μg/ml), BBA70 or gelatin as a neg...
Limited proteolysis of C3b by C3b inactivator (factor I) consists of a two-step reaction; rapid clea...
Upon host infection, the human pathogenic microbe Staphylococcus aureus (S. aureus) immediately face...
Upon host infection, the human pathogenic microbe Staphylococcus aureus (S. aureus) immediately face...
<p>(A) Plasminogen bound to Sbi and Efb (lane 1 and 2). The accuracy of the recombinant staphylococc...
<p>(A) Plasmin (PL) bound to Sbi, Efb, and to the borrelial CRASP-5 converted a chromogenic substrat...
Upon host infection, the human pathogenic microbe Staphylococcus aureus (S. aureus) immediately face...
<p>Western blot analysis of recombinant C2 fragment (A) or NHBA full-length protein (B) incubated fo...
<p>(A) Microtiter plate wells coated with ECM (MaxGel™) were exposed to the indicated concentrations...
<p>ELISA plates were either coated with PLY, or mannan, or immune complexes (as either positive or n...
<p><b>A</b>: Formation of C3a in 2.5% serum incubated in wells coated with fibrin, the known complem...
<p>Proteolysis of <sup>125</sup>I-C3b was analyzed by the intensity of the α’-chain in autoradiograp...
<p>A-C) Cleavage of human complement factors A) C3, B) C3a and C) C5a by whole cell pellets (4x10<su...
<p>(A) Sbi 3–4 (lane 5–6) and Efb-C (lane 8–9) enhanced cleavage of C3b by plasmin, as seen by the a...
<p>(A+B) Plasminogen (PLG) bound to the fragments 3–4 of Sbi (A) and the C-terminus of Efb (B). Sbi ...
<p>Microtiter plates were coated with recombinant Tuf proteins (10 μg/ml), BBA70 or gelatin as a neg...
Limited proteolysis of C3b by C3b inactivator (factor I) consists of a two-step reaction; rapid clea...
Upon host infection, the human pathogenic microbe Staphylococcus aureus (S. aureus) immediately face...
Upon host infection, the human pathogenic microbe Staphylococcus aureus (S. aureus) immediately face...
<p>(A) Plasminogen bound to Sbi and Efb (lane 1 and 2). The accuracy of the recombinant staphylococc...
<p>(A) Plasmin (PL) bound to Sbi, Efb, and to the borrelial CRASP-5 converted a chromogenic substrat...
Upon host infection, the human pathogenic microbe Staphylococcus aureus (S. aureus) immediately face...
<p>Western blot analysis of recombinant C2 fragment (A) or NHBA full-length protein (B) incubated fo...
<p>(A) Microtiter plate wells coated with ECM (MaxGel™) were exposed to the indicated concentrations...
<p>ELISA plates were either coated with PLY, or mannan, or immune complexes (as either positive or n...
<p><b>A</b>: Formation of C3a in 2.5% serum incubated in wells coated with fibrin, the known complem...
<p>Proteolysis of <sup>125</sup>I-C3b was analyzed by the intensity of the α’-chain in autoradiograp...
<p>A-C) Cleavage of human complement factors A) C3, B) C3a and C) C5a by whole cell pellets (4x10<su...